3rd Joint Call - 2011 - Results of the call

Following the recommendations of the Peer Review Panel that were based on overall quality assessment of all eligible applications received in response to the 3rd Joint Transnational Call, the Call Steering Committee of EuroNanoMed selected the following projects for funding (alphabetic order):

ACRONYM

FULL TITLE

COORDINATOR

COORDINATING COUNTRY

CheTherDel

Chemo-hyperthermal Delivery – Combined chemo-hyperthermal control of hepatic tumors, based on microwave-activated subendothelial-targeted nano-assemblies

Summary (PDF)

Mihail-Gabriel Dimofte (University of Medicine and Pharmacy „Gr.T. Popa” Iasi)

Romania

Dia-AMYL

AMYLOID PEPTIDE GRAFTED TO GD-NANOPARTICLE FOR AMYLOIDOSIS DIAGNOSIS

Summary (PDF)

Vincent Forge (Commissariat à l’Energie Atomique et aux Energies Alternatives-CEA)

France

FONDiag

Fluorescent Organic Nanocrystals for the Early Diagnosis of Esophageal and Colon Cancer

Summary (PDF)

Suzanne Fery-Forgues (Laboratoire IMRCP-CNRS UMR 5623)

France

META

MEtastases Targeting Aptamers

Summary (PDF)

Günter Mayer (University of Bonn)

Germany

nAngioFrac

Angiogenic nanostructured materials for non-consolidating bone fractures

Summary (PDF)

Josep A. Planell (Biomedical Research Networking center in Bioengineering, Biomaterials and Nanomedicine-CIBER-BBN)

Spain

NanoDiaMed

Molecular diagnosis of multifactorial psychiatric diseases: functional validation of identified gene variants using nanobodies coupled to fluorescent diamond nanoparticles

Summary (PDF)

Michel Simonneau (Institut National de la Santé et de a Recherche Médicale-INSERM)

France

NANOVAXID*

Design of novel anti-idiotype vaccines adjuvanted with RNA-based nanoparticles: entry into nanotechnology based personalized cancer immunotherapy

Summary (PDF)

Maurizio Bendandi (Clínica Universidad de Navarra-CUN)

Spain

STRUCTGEL

Nanostructured Gel for Cellular Therapy of Degenerative Skeletal Disorders

Summary (PDF)

George Altankov (Biomedical Research Networking center in Bioengineering, Biomaterials and Nanomedicine-CIBER-BBN)

Spain

The final budget of each funded project partner is to be negotiated and specified by the relevant funding agency.

Peer Review Panel MEETING (6-7th September 2011, Venice – Italy): list of participating evaluators (PDF).

*Due to administrative reasons (breakup of the consortium), the NANOVAXID project cannot be funded under the frame of the “EuroNanoMed Joint Transnational Call 2011″.

Share: